Valeant - price wars | Lex
- 5 years ago
► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Valeant’s stock has plummeted as critics allege price gouging in the pharma group’s portfolio of generic drugs. Lex’s Robert Armstrong and Jonathan Eley discuss whether the sell-off is overdone.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
Valeant’s stock has plummeted as critics allege price gouging in the pharma group’s portfolio of generic drugs. Lex’s Robert Armstrong and Jonathan Eley discuss whether the sell-off is overdone.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes